To assess whether there is a higher incidence of BRCA1/2 mutations in MC tumors than in AC tumors, we performed an analysis of a cohort of targeted sequencing of 1134 metastatic colorectal cancer samples [19] (hereby the MSKCC database). This evidence concerns the gene BRCA1 and colorectal cancer.